Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 224

1.

Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS).

Baraliakos X, Østergaard M, Gensler LS, Poddubnyy D, Lee EY, Kiltz U, Martin R, Sawata H, Readie A, Porter B; SURPASS Study Group.

Clin Drug Investig. 2020 Jan 25. doi: 10.1007/s40261-020-00886-7. [Epub ahead of print]

PMID:
31983056
2.

Response to: 'Frequency of MRI changes suggestive of axial spondyloarthritis in the axial in a large population-based cohort of individuals aged <45 years' by Parperis.

Baraliakos X, Richter A, Schmidt CO, Braun J.

Ann Rheum Dis. 2020 Jan 3. pii: annrheumdis-2019-216798. doi: 10.1136/annrheumdis-2019-216798. [Epub ahead of print] No abstract available.

PMID:
31900303
3.

[Clinical significance of determination of DFS70 antibodies to rule out connective tissue diseases].

Kiefer D, von Brunn M, Baraliakos X, Andreica I, Braun J.

Z Rheumatol. 2019 Dec 30. doi: 10.1007/s00393-019-00741-x. [Epub ahead of print] German.

PMID:
31889213
4.

Reply to: Bone marrow oedema on sacroiliac/spine MRI: is it really a sign of objective inflammation warranting treatment?

Baraliakos X, Anderson JK.

Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 122(6):11-12. Epub 2019 Dec 12. No abstract available.

5.

[Imaging of psoriatic arthritis and aspects of radiographic progression].

Baraliakos X, Kleyer A, Simon D, Köhm M, Ohrndorf S, Sewerin P.

Z Rheumatol. 2019 Dec 10. doi: 10.1007/s00393-019-00735-9. [Epub ahead of print] Review. German.

PMID:
31822993
6.

[Imaging in patients with axial spondylarthritis with focus on new bone formation].

Baraliakos X, Braun J.

Z Rheumatol. 2019 Dec 10. doi: 10.1007/s00393-019-00732-y. [Epub ahead of print] Review. German.

PMID:
31822992
7.

[Biosimilars and the nocebo effect].

Braun J, Tsiami S, Buehring B, Kiefer D, Andreica I, Baraliakos X, Kiltz U.

Z Rheumatol. 2019 Dec 4. doi: 10.1007/s00393-019-00729-7. [Epub ahead of print] German.

PMID:
31802197
8.

Do NSAIDs affect radiographic progression in axial SpA?

Braun J, Baraliakos X.

Nat Rev Rheumatol. 2020 Jan;16(1):9-10. doi: 10.1038/s41584-019-0341-4. No abstract available.

PMID:
31758152
9.

Frequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a large population-based cohort of individuals aged <45 years.

Baraliakos X, Richter A, Feldmann D, Ott A, Buelow R, Schmidt CO, Braun J.

Ann Rheum Dis. 2019 Nov 19. pii: annrheumdis-2019-215553. doi: 10.1136/annrheumdis-2019-215553. [Epub ahead of print]

PMID:
31744822
10.

Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W).

Dougados M, Wei JC, Landewé R, Sieper J, Baraliakos X, Van den Bosch F, Maksymowych WP, Ermann J, Walsh JA, Tomita T, Deodhar A, van der Heijde D, Li X, Zhao F, Bertram CC, Gallo G, Carlier H, Gensler LS; COAST-V and COAST-W Study Groups.

Ann Rheum Dis. 2019 Nov 4. pii: annrheumdis-2019-216118. doi: 10.1136/annrheumdis-2019-216118. [Epub ahead of print]

11.

The impact of sex and disease classification on patient-reported outcome measures in axial spondyloarthritis: a descriptive prospective cross-sectional study.

Andreasen RA, Kristensen LE, Egstrup K, Baraliakos X, Strand V, Horn HC, Hansen IMJ, Christensen R, Ellingsen T.

Arthritis Res Ther. 2019 Oct 29;21(1):221. doi: 10.1186/s13075-019-2012-x.

12.

Does psoriatic axial spondyloarthritis phenotype correlate with imaging morphotype?

Gensler LS, Szumski A, Jones HE, Baraliakos X.

Clin Exp Rheumatol. 2019 Oct 1. [Epub ahead of print]

PMID:
31577217
13.

Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study.

Baraliakos X, Braun J, Deodhar A, Poddubnyy D, Kivitz A, Tahir H, Van den Bosch F, Delicha EM, Talloczy Z, Fierlinger A.

RMD Open. 2019 Sep 3;5(2):e001005. doi: 10.1136/rmdopen-2019-001005. eCollection 2019.

14.

Treat to Target in Axial Spondyloarthritis.

Nikiphorou E, Baraliakos X.

Rheum Dis Clin North Am. 2019 Nov;45(4):519-535. doi: 10.1016/j.rdc.2019.07.003. Epub 2019 Aug 17. Review.

PMID:
31564294
15.

[Erratum to: Epionics SPINE-use of an objective method to examine spinalmobility in patients with axial spondyloarthritis].

Kiefer D, Baraliakos X, Bühring B, Kiltz U, Braun J.

Z Rheumatol. 2019 Oct;78(8):773-774. doi: 10.1007/s00393-019-00715-z. German. No abstract available.

PMID:
31541287
16.

[Early recognition and screening consultation: a necessary way to improve early detection and treatment in rheumatology? : Overview of the early recognition and screening consultation models for rheumatic and musculoskeletal diseases in Germany].

Benesova K, Lorenz HM, Lion V, Voigt A, Krause A, Sander O, Schneider M, Feuchtenberger M, Nigg A, Leipe J, Briem S, Tiessen E, Haas F, Rihl M, Meyer-Olson D, Baraliakos X, Braun J, Schwarting A, Dreher M, Witte T, Assmann G, Hoeper K, Schmidt RE, Bartz-Bazzanella P, Gaubitz M, Specker C.

Z Rheumatol. 2019 Oct;78(8):722-742. doi: 10.1007/s00393-019-0683-y. Review. German.

PMID:
31468170
17.

[Epionics SPINE-use of an objective method to examine spinal mobility in patients with axial spondyloarthritis].

Kiefer D, Baraliakos X, Bühring B, Kiltz U, Braun J.

Z Rheumatol. 2019 Aug 29. doi: 10.1007/s00393-019-00692-3. [Epub ahead of print] German. Erratum in: Z Rheumatol. 2019 Oct;78(8):773-774.

PMID:
31468167
18.

Nonsteroidal anti-inflammatory drugs and cardiovascular risk - a matter of indication.

Braun J, Baraliakos X, Westhoff T.

Semin Arthritis Rheum. 2019 Aug 1. pii: S0049-0172(19)30211-2. doi: 10.1016/j.semarthrit.2019.07.012. [Epub ahead of print] Review.

PMID:
31439354
19.

MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group.

Maksymowych WP, Lambert RG, Østergaard M, Pedersen SJ, Machado PM, Weber U, Bennett AN, Braun J, Burgos-Vargas R, de Hooge M, Deodhar AA, Eshed I, Jurik AG, Hermann KA, Landewé RB, Marzo-Ortega H, Navarro-Compán V, Poddubnyy D, Reijnierse M, Rudwaleit M, Sieper J, Van den Bosch FE, van der Heijde D, van der Horst-Bruinsma IE, Wichuk S, Baraliakos X.

Ann Rheum Dis. 2019 Nov;78(11):1550-1558. doi: 10.1136/annrheumdis-2019-215589. Epub 2019 Aug 17.

PMID:
31422357
20.

Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations.

Kedra J, Radstake T, Pandit A, Baraliakos X, Berenbaum F, Finckh A, Fautrel B, Stamm TA, Gomez-Cabrero D, Pristipino C, Choquet R, Servy H, Stones S, Burmester G, Gossec L.

RMD Open. 2019 Jul 18;5(2):e001004. doi: 10.1136/rmdopen-2019-001004. eCollection 2019.

21.

Imaging in the preclinical phases of rheumatoid arthritis.

Zabotti A, Finzel S, Baraliakos X, Aouad K, Ziade N, Iagnocco A.

Clin Exp Rheumatol. 2019 Jul 25. [Epub ahead of print] Review.

PMID:
31376263
22.

Observation by Magnetic Resonance Imaging of Sacroiliac Joint Ankylosis in Young Spondyloarthritis Patients Receiving Biologic Therapy: Comment on the Article by Bray et al.

Braun J, Kiltz U, Baraliakos X.

Arthritis Rheumatol. 2019 Dec;71(12):2128-2129. doi: 10.1002/art.41050. Epub 2019 Oct 21. No abstract available.

PMID:
31328408
23.

Implementation and role of modern musculoskeletal imaging in rheumatological practice in member countries of EULAR.

Mandl P, Ciechomska A, Terslev L, Baraliakos X, Conaghan PG, D'Agostino MA, Iagnocco A, van der Laken CJ, Ostergaard M, Naredo E.

RMD Open. 2019 Jun 25;5(2):e000950. doi: 10.1136/rmdopen-2019-000950. eCollection 2019.

24.

[Rheumatological care in the Rheumazentrum Ruhrgebiet Rheumatism Center-a model for conurbations].

Braun J, Kiltz U, Andreica I, Buehring B, Guminski B, Häusler U, Kavruk H, Kiefer D, Lochowski R, Mintrop B, Baraliakos X.

Z Rheumatol. 2019 Oct;78(8):753-764. doi: 10.1007/s00393-019-0663-2. Review. German.

PMID:
31286192
25.

Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis.

Mease P, Walsh JA, Baraliakos X, Inman R, de Vlam K, Wei JC, Hunter T, Gallo G, Sandoval D, Zhao F, Dong Y, Bolce R, Marzo-Ortega H.

Rheumatol Ther. 2019 Sep;6(3):435-450. doi: 10.1007/s40744-019-0165-3. Epub 2019 Jun 28.

26.

EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases.

Gossec L, Kedra J, Servy H, Pandit A, Stones S, Berenbaum F, Finckh A, Baraliakos X, Stamm TA, Gomez-Cabrero D, Pristipino C, Choquet R, Burmester GR, Radstake TRDJ.

Ann Rheum Dis. 2020 Jan;79(1):69-76. doi: 10.1136/annrheumdis-2019-215694. Epub 2019 Jun 22.

PMID:
31229952
27.

Imaging in axial spondyloarthritis: Changing concepts and thresholds.

Weber U, Baraliakos X.

Best Pract Res Clin Rheumatol. 2018 Jun;32(3):342-356. doi: 10.1016/j.berh.2018.10.009. Epub 2018 Nov 17. Review.

PMID:
31171307
28.

[Multi-Faceted Symptoms with Joint Pain, Exanthema and Eye Involvement].

Tsiami S, Regel A, Baraliakos X, Braun J, Kiltz U.

Dtsch Med Wochenschr. 2019 Jun;144(11):759-763. doi: 10.1055/a-0859-3151. Epub 2019 Jun 4. German.

PMID:
31163477
29.

What constitutes the fat signal detected by MRI in the spine of patients with ankylosing spondylitis? A prospective study based on biopsies obtained during planned spinal osteotomy to correct hyperkyphosis or spinal stenosis.

Baraliakos X, Boehm H, Bahrami R, Samir A, Schett G, Luber M, Ramming A, Braun J.

Ann Rheum Dis. 2019 Sep;78(9):1220-1225. doi: 10.1136/annrheumdis-2018-214983. Epub 2019 May 23.

PMID:
31122911
30.

Structural progression in axial spondyloarthritis.

Aouad K, Ziade N, Baraliakos X.

Joint Bone Spine. 2019 May 5. pii: S1297-319X(19)30069-7. doi: 10.1016/j.jbspin.2019.04.006. [Epub ahead of print]

PMID:
31067506
31.

Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data.

Deodhar A, Mease PJ, McInnes IB, Baraliakos X, Reich K, Blauvelt A, Leonardi C, Porter B, Das Gupta A, Widmer A, Pricop L, Fox T.

Arthritis Res Ther. 2019 May 2;21(1):111. doi: 10.1186/s13075-019-1882-2.

32.

Added Value of Anti-CD74 Autoantibodies in Axial SpondyloArthritis in a Population With Low HLA-B27 Prevalence.

Ziade NR, Mallak I, Merheb G, Ghorra P, Baerlecken N, Witte T, Baraliakos X.

Front Immunol. 2019 Mar 26;10:574. doi: 10.3389/fimmu.2019.00574. eCollection 2019.

33.

Surgical treatment of anterior cervical osteophytes causing dysphagia.

Ruetten S, Baraliakos X, Godolias G, Komp M.

J Orthop Surg (Hong Kong). 2019 May-Aug;27(2):2309499019837424. doi: 10.1177/2309499019837424.

PMID:
30909798
34.

Tapering bDMARDs in axial SpA - what is the current evidence?

Ziade NR, Baraliakos X.

Nat Rev Rheumatol. 2019 Jun;15(6):322-324. doi: 10.1038/s41584-019-0201-2. No abstract available.

PMID:
30903025
35.

Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis.

Braun J, Baraliakos X, Kiltz U, Krüger K, Burmester GR, Wassenberg S, Thomas MH.

J Rheumatol. 2020 Jan;47(1):35-41. doi: 10.3899/jrheum.181040. Epub 2019 Mar 15.

36.

[RABBIT-SpA: a new disease register for axial spondyloarthritis and psoriatic arthritis].

Regierer AC, Weiß A, Baraliakos X, Zink A, Listing J, Strangfeld A.

Z Rheumatol. 2019 Mar 12. doi: 10.1007/s00393-019-0613-z. [Epub ahead of print] German.

PMID:
30874933
37.

Detection of Erosions in Sacroiliac Joints of Patients with Axial Spondyloarthritis Using the Magnetic Resonance Imaging Volumetric Interpolated Breath-hold Examination.

Baraliakos X, Hoffmann F, Deng X, Wang YY, Huang F, Braun J.

J Rheumatol. 2019 Nov;46(11):1445-1449. doi: 10.3899/jrheum.181304. Epub 2019 Feb 15.

PMID:
30770520
38.

HLA-B27 prevalence in axial spondyloarthritis patients and in blood donors in a Lebanese population: Results from a nationwide study.

Ziade N, Abi Karam G, Merheb G, Mallak I, Irani L, Alam E, Messaykeh J, Menassa J, Mroue' K, Uthman I, Masri AF, Ghorra P, Witte T, Baraliakos X.

Int J Rheum Dis. 2019 Apr;22(4):708-714. doi: 10.1111/1756-185X.13487. Epub 2019 Feb 6.

PMID:
30729696
39.

The need for comparative data in spondyloarthritis.

Choy E, Baraliakos X, Behrens F, D'Angelo S, de Vlam K, Kirkham BW, Østergaard M, Schett GA, Rissler M, Chaouche-Teyara K, Perella C.

Arthritis Res Ther. 2019 Jan 22;21(1):32. doi: 10.1186/s13075-019-1812-3.

40.

Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study.

Braun J, Baraliakos X, Deodhar A, Poddubnyy D, Emery P, Delicha EM, Talloczy Z, Porter B.

Rheumatology (Oxford). 2019 May 1;58(5):859-868. doi: 10.1093/rheumatology/key375.

41.

Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies.

Braun J, Deodhar A, Landewé R, Baraliakos X, Miceli-Richard C, Sieper J, Quebe-Fehling E, Martin R, Porter B, Gandhi KK, van der Heijde D; MEASURE 1 and MEASURE 2 study groups.

RMD Open. 2018 Nov 21;4(2):e000749. doi: 10.1136/rmdopen-2018-000749. eCollection 2018.

42.

Active and chronic sacroiliitis, spondylitis and enthesitis, How specific are imaging findings for axial spondyloarthritis?

Braun J, Baraliakos X.

Rheumatology (Oxford). 2019 Aug 1;58(8):1321-1324. doi: 10.1093/rheumatology/key372. No abstract available.

PMID:
30561682
43.

The role of C-reactive protein as a predictor of treatment response in patients with ankylosing spondylitis.

Baraliakos X, Szumski A, Koenig AS, Jones H.

Semin Arthritis Rheum. 2019 Jun;48(6):997-1004. doi: 10.1016/j.semarthrit.2018.10.019. Epub 2018 Nov 2.

PMID:
30473179
44.

Imaging in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and osteoarthritis: An international viewpoint on the current knowledge and future research priorities.

Baraliakos X, Conaghan PG, D'Agostino MA, Maksymowych W, Naredo E, Ostergaard M, Schett G, Emery P.

Eur J Rheumatol. 2019 Jan;6(1):38-47. doi: 10.5152/eurjrheum.2018.18121. Review.

45.

Sensitivity and Specificity of Autoantibodies Against CD74 in Nonradiographic Axial Spondyloarthritis.

Riechers E, Baerlecken N, Baraliakos X, Achilles-Mehr Bakhsh K, Aries P, Bannert B, Becker K, Brandt-Jürgens J, Braun J, Ehrenstein B, Euler HH, Fleck M, Hein R, Karberg K, Köhler L, Matthias T, Max R, Melzer A, Meyer-Olson D, Rech J, Rockwitz K, Rudwaleit M, Schmidt RE, Schweikhard E, Sieper J, Stille C, von Hinüber U, Wagener P, Weidemann HF, Zinke S, Witte T.

Arthritis Rheumatol. 2019 May;71(5):729-735. doi: 10.1002/art.40777. Epub 2019 Mar 20.

PMID:
30418704
46.

The Impact of Fibromyalgia in Spondyloarthritis: From Classification Criteria to Outcome Measures.

Alunno A, Carubbi F, Stones S, Gerli R, Giacomelli R, Baraliakos X.

Front Med (Lausanne). 2018 Oct 24;5:290. doi: 10.3389/fmed.2018.00290. eCollection 2018. Review.

47.

[Differential diagnosis of axial spondyloarthritis-axSpA mimics].

Braun J, Baraliakos X, Buehring B, Fruth M, Kiltz U.

Z Rheumatol. 2019 Feb;78(1):31-42. doi: 10.1007/s00393-018-0557-8. Review. German.

PMID:
30377767
48.

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial.

van der Heijde D, Baraliakos X, Gensler LS, Maksymowych WP, Tseluyko V, Nadashkevich O, Abi-Saab W, Tasset C, Meuleners L, Besuyen R, Hendrikx T, Mozaffarian N, Liu K, Greer JM, Deodhar A, Landewé R.

Lancet. 2018 Dec 1;392(10162):2378-2387. doi: 10.1016/S0140-6736(18)32463-2. Epub 2018 Oct 22.

49.

Learning from the youngsters: ixekizumab in active ankylosing spondylitis.

Baraliakos X, Braun J.

Lancet. 2018 Dec 8;392(10163):2415-2416. doi: 10.1016/S0140-6736(18)32340-7. Epub 2018 Oct 22. No abstract available.

PMID:
30360968
50.

The role of 18F-FDG positron emission tomography for the diagnosis of vasculitides.

Braun J, Baraliakos X, Fruth M.

Clin Exp Rheumatol. 2018 Sep-Oct;36 Suppl 114(5):108-114. Epub 2018 Oct 1. Review.

Supplemental Content

Loading ...
Support Center